Arixtra (Fondaparinux Sodium)

Arixtra Information:

Buy Arixtra

Arixtra (Fondaparinux Sodium) is a medication used in the prevention and treatment of blood clots. Its uses include:
• Deep Vein Thrombosis (DVT) Prevention: Commonly prescribed to prevent blood clot formation in the deep veins of the legs, especially for patients undergoing major orthopedic surgeries such as hip or knee replacement. DVT can be a serious complication of these surgeries. Arixtra is also used to prevent venous thrombosis in individuals with a history of heparin-induced thrombocytopenia, leading to low platelet counts due to heparin;

• Deep Vein Thrombosis (DVT) Treatment: Arixtra is used to treat established DVT, which occurs when blood clots form in the deep veins, often in the legs. Arixtra helps dissolve these clots and prevent them from enlarging;

• Pulmonary Embolism (PE) Treatment: Arixtra is used to treat pulmonary embolism, a condition where blood clots travel to the lungs, potentially causing life-threatening complications;

• Unstable Angina and Non-ST Segment Elevation Myocardial Infarction (NSTEMI): Arixtra may be used in combination with other medications to manage acute coronary syndromes such as unstable angina and NSTEMI.

Arixtra's active ingredient is Fondaparinux Sodium, belonging to the class of drugs known as anticoagulants or antithrombotic agents. Arixtra works by inhibiting the formation of blood clots, specifically by targeting a clotting factor called Factor Xa. This factor plays a crucial role in the blood clotting cascade. By blocking Factor Xa, Arixtra helps prevent the formation of blood clots, reducing the risk of conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and other blood clot-related disorders.

Generic Arixtra from Canada

Canada Drugs Online is proud to serve you the brand Arixtra from the United Kingdom manufactured by GSK. The generic form of this medication is currently not available. Please call us toll-free at 1-877-900-3784 for details.

CanadaDrugsOnline.com also carries other Anticoagulant medications such as Eliquis and Pradaxa.

Arixtra Side Effects:

Common mild side effects of this medication may include pain, bruising, redness, and swelling at the injection site, headache, nausea, vomiting, swelling of the hands or feet, and fever. If any of these effects persist or worsen, please inform your doctor immediately.

Possible serious side effects include easy bruising and bleeding, dark urine, yellowing of the skin, shortness of breath, coughing up blood, chest pain, cold or blue fingers or toes, unusual dizziness, fainting, fast or irregular heartbeat, joint/muscle pain, mental or mood changes such as confusion, numbness or tingling sensations in the hands or feet, severe abdominal pain, passage of dark tarry or bloody stools, bloody urine, vomit that resembles coffee grounds, vision problems, weakness on one side of the body, trouble speaking, seizures, difficulty moving, severe body itching and rash, swelling of your face, lips, tongue, or throat, difficulty breathing, and dizziness. If you notice any of these severe side effects, stop taking this medication and seek immediate medical attention. Additionally, inform your doctor about any other side effects not listed here.

Arixtra is effective in preventing and treating blood clots and related disorders. Its efficacy varies depending on the specific medical condition and the patient's individual factors, making it a valuable option for clot prevention and management. However, its use should always be guided by a healthcare provider to ensure the best balance between effectiveness and safety. It has a half-life of 17-21 hours.

Arixtra Directions:

Arixtra is available in the form of a sterile, preservative-free injectable solution in a pre-filled syringe. It should be administered under the skin of the abdomen by your doctor. Your doctor will determine the best dosing schedule for you. However, if you are using this medication at home, learn how to prepare and administer it from your doctor. Also, ensure you carefully read the leaflet in the medication pack for more detailed usage instructions. Change the injection site each time to minimize injury under the skin. Store this medication at room temperature (below 30⁰C) and do not freeze. Keep it away from children and pets.

Arixtra Precautions:

Before using Arixtra, make sure to inform your doctor about any medical conditions you have had or currently have, including the following: • Allergic reaction to Fondaparinux, other ingredients of Arixtra, or any other medication;
• Bleeding or blood disorders such as low platelet counts;
• Eye problems;
• Heart diseases;
• High blood pressure;
• Kidney disease;
• Liver disease;
• Low body weight less than 50 kg;
• Peptic ulcer disease;
• Seizure disorders;
• Spinal deformity or recent spine, eye, or brain surgery;
• Stroke

Avoid consuming alcohol and smoking cigarettes while taking this medication, as these substances can increase the risk of side effects. Regular monitoring of the blood clotting profile may be necessary to ensure the medication is effective and the dose is appropriate. Be cautious while using sharp objects like razor blades, as this medication can cause increased bleeding. Additionally, avoid activities such as contact sports while using Arixtra. Do not use this medication during pregnancy or while breastfeeding unless recommended by your doctor after a careful evaluation of its risks and benefits. It is not safe to use in individuals younger than 18 years. Fondaparinux can interact with other drugs, supplements, and foods, leading to unwanted side effects or reduced effectiveness. Some of these drugs include:
• Antibiotics like cephalosporins;
• Antiplatelet drugs such as Clopidogrel;
• Blood thinners such as Warfarin or Rivaroxaban;
• Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen;
• Thrombolytic agents such as alteplase.

Therefore, you must inform your healthcare provider about all the medications, including herbal medications and supplements, that you are taking before starting Arixtra to prevent drug interactions.